日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults

一项双盲、随机对照研究,旨在比较口服药代动力学增强型阿莫西林-克拉维酸钾(2000/125毫克)与阿莫西林-克拉维酸钾(875/125毫克)治疗成人社区获得性细菌性肺炎的疗效和安全性,两种药物均每日两次,疗程7天。

File, T M Jr; Lode, H; Kurz, H; Kozak, R; Xie, H; Berkowitz, E

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

成人社区获得性肺炎诊疗指南。美国传染病学会

Bartlett, J G; Dowell, S F; Mandell, L A; File, T M Jr; Musher, D M; Fine, M J

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

一项多中心随机研究比较了静脉注射和/或口服左氧氟沙星与头孢曲松和/或头孢呋辛酯治疗成人社区获得性肺炎的疗效和安全性。

File, T M Jr; Segreti, J; Dunbar, L; Player, R; Kohler, R; Williams, R R; Kojak, C; Rubin, A

Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group

氧氟沙星与标准疗法治疗需要住院治疗的社区获得性肺炎的疗效比较。肺炎研究组

Plouffe, J F; Herbert, M T; File, T M Jr; Baird, I; Parsons, J N; Kahn, J B; Rielly-Gauvin, K T

Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein

对寡聚体人类免疫缺陷病毒1型包膜蛋白的体液免疫应答

Richardson, T M Jr; Stryjewski, B L; Broder, C C; Hoxie, J A; Mascola, J R; Earl, P L; Doms, R W

Yield, clinical significance, and cost of a combination BACTEC plus Septi-Chek blood culture system

BACTEC联合Septi-Chek血培养系统的产量、临床意义和成本

Thomson, R B Jr; File, T M Jr; Tan, J S; Evans, B L

Recurrent carotid stenosis. Results and complications of 57 operations

复发性颈动脉狭窄。57例手术的结果和并发症

Piepgras, D G; Sundt, T M Jr; Marsh, W R; Mussman, L A; Fode, N C